EUVIMEDEUVIMED entdecken
Crossref

Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer’s Disease Diagnosis in Cognitively Impaired Patients

Matthieu Lilamand iD, Elodie Bouaziz-Amar, Julien Dumurgier, Emmanuel Cognat iD, Claire Hourregue, François Mouton-Liger, Manuel Sanchez iD, Anne-Cécile Troussière, Matthieu Martinet, Jacques Hugon, Claire Paquet

The Journals of Gerontology: Series A · 2023

DOI: 10.1093/gerona/glac234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology: Series A, 2023. Verfasst von Matthieu Lilamand und 10 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM Unit UMR S-1144, Paris, France. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction and dysregulation of leptin signaling have been linked to Alzheimer’s disease (AD)’s pathophysiology. The objectives of this study were to examine the associations between plasma leptin, cerebrospinal fluid (CSF), beta-amyloid (Aβ), and tau biomarkers (AT[N] status) and with the stage of cognitive impairment.

Methods

Cross-sectional analysis of data from cognitively impaired patients from a tertiary memory clinic. Plasma leptin levels were compared according to the stage of cognitive impairment and biomarker profiles, using the AT(N) classification. Linear regression models were performed to examine the relationship between leptin and CSF biomarkers. Results were adjusted for age, gender, body mass index (BMI), and APOE ε4. In a subgroup of A+T+ individuals, we compared the 2-year evolution of Mini-Mental State Examination scores, according to the participants’ tertile of plasma leptin levels.

Results

We included 1 036 participants (age 68.7 ± 9.1, females = 54.1%). A+T+ and A+T− patients had significantly lower plasma leptin levels than amyloid negative participants (p < .01). CSF Aβ concentration was significantly associated with lower plasma leptin β = −4.3 (1.5), p = .005 unadjusted; and β = −3.4 (1.6), p = .03 after adjustment for age, female gender, BMI, and APOE ε4. Patients with major neurocognitive disorder due to AD had a difference of leptin of −7.3 ng/mL 95% confidence interval (CI; −11.8; −2.8), p = .0002, compared to individuals with other causes of cognitive impairment. Leptin was not associated with the slope of cognitive decline.

Conclusion

Plasma leptin levels were associated with CSF Aβ and with the diagnosis of AD confirmed by CSF biomarkers, suggesting a molecular interplay between leptin metabolism and brain amyloid deposition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansFemaleAgedApolipoprotein E4Cross-Sectional Studiestau ProteinsAmyloid beta-PeptidesBiomarkersAmyloidPeptide Fragments

Stichwörter der Autor:innen

Alzheimer’s diseaseBiomarkersLeptinMetabolic dysfunction

Substanzen

Apolipoprotein E4tau ProteinsAmyloid beta-PeptidesBiomarkersAmyloidPeptide Fragments

Autor:innen und Institutionen

  • Université Paris Cité, INSERM Unit UMR S-1144, Paris, France.
  • Department of Geriatrics, Lariboisière-Fernand Widal Hospital GHU AP-HP.Nord, Paris, France.
  • Biochemistry Department, Lariboisière Hospital GHU AP-HP.Nord, Paris, France.
  • Cognitive Neurology Center, Lariboisière-Fernand Widal Hospital GHU AP-HP.Nord, Paris, France.
  • Department of Geriatrics, Bichat GHU AP-HP.Nord, Paris, France.
  • Neurologist, 23 Esp. du Grand Siècle, Versailles, France.

ORCID-Profile: Matthieu Lilamand, Emmanuel Cognat, Manuel Sanchez

Zitieren

APA

Lilamand, M., Bouaziz-Amar, E., Dumurgier, J., Cognat, E., Hourregue, C., Mouton-Liger, F., Sanchez, M., Troussière, A. C., Martinet, M., Hugon, J., & Paquet, C. (2023). Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer’s Disease Diagnosis in Cognitively Impaired Patients. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glac234

Vancouver

Lilamand M, Bouaziz-Amar E, Dumurgier J, Cognat E, Hourregue C, Mouton-Liger F, et al. Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer’s Disease Diagnosis in Cognitively Impaired Patients. The Journals of Gerontology: Series A. 2023. doi:10.1093/gerona/glac234

BibTeX
@article{Lilamand2023,
  author = {Lilamand, Matthieu and Bouaziz-Amar, Elodie and Dumurgier, Julien and Cognat, Emmanuel and Hourregue, Claire and Mouton-Liger, François and Sanchez, Manuel and Troussière, Anne-Cécile and Martinet, Matthieu and Hugon, Jacques and Paquet, Claire},
  title = {Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer’s Disease Diagnosis in Cognitively Impaired Patients},
  journal = {The Journals of Gerontology: Series A},
  year = {2023},
  doi = {10.1093/gerona/glac234}
}
Kostenlos starten →